Cipla Quality Chemical Industries Limited (CiplaQCIL) is a state-of-the-art pharmaceutical manufacturing company located in Kampala, Uganda. The company manufactures Anti-retroviral (ARVs), Artemisinin-based Combination Therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, Malaria and Hepatitis.

Latest Updates

September 19, 2018

Cipla Quality Chemical Industries Limited Bell Ringing and First Day of Trading on the Uganda Securities Exchange

Kampala. Cipla Quality Chemical Industries Limited (CiplaQCIL), a leading pharmaceutical manufacturing company in Sub Saharan Africa operating in Uganda, today officially listed on the Uganda Securities […]
September 19, 2018

Cipla Quality Chemical Industries Ltd: Changes to Executive Management

In accordance with its continuing listing obligations, Cipla Quality Chemical Industries Ltd (“CiplaQCIL”) hereby informs its shareholders and general public of the following changes in its […]
September 14, 2018

IPO Results Announcement

Uganda, Kampala 14th September 2018 – Cipla Quality Chemical Industries (“CiplaQCIL”) (Ticker: CQCIL) today announces the successful allocation of its Initial Public Offering (“IPO”) on the […]